Edition:
India

People: Exact Sciences Corp (EXAS.OQ)

EXAS.OQ on NASDAQ Stock Exchange Capital Market

86.69USD
7 Aug 2020
Change (% chg)

$-3.71 (-4.10%)
Prev Close
$90.40
Open
$90.00
Day's High
$90.22
Day's Low
$85.18
Volume
468,713
Avg. Vol
475,715
52-wk High
$123.11
52-wk Low
$35.27

Conroy, Kevin 

Mr. Kevin T. Conroy serves as Chairman of the Board, President, Chief Executive Officer of the Company. Mr. Conroy has served as our President and Chief Executive Officer since April 2009, as a director since March 2009 and as Chairman of our Board of Directors since March 2014. Mr. Conroy served as president and chief executive officer of Third Wave Technologies, Inc., a molecular diagnostics company, from December 2005 until the acquisition of Third Wave by Hologic, Inc. in July 2008. He joined Third Wave in July 2004 and served as general counsel until December 2005. Prior to joining Third Wave, Mr. Conroy held leadership positions at GE Healthcare and practiced intellectual property law in private practice. Mr. Conroy also serves as a director of Epizyme, Inc., a clinical-stage biopharmaceutical company (NASDAQ: EPZM). He earned a bachelor's degree in electrical engineering at Michigan State University and a JD from the University of Michigan.

Basic Compensation

Total Annual Compensation, USD 1,792,420
Restricted Stock Award, USD 14,950,000
Long-Term Incentive Plans, USD --
All Other, USD 1,974,140
Fiscal Year Total, USD 18,716,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kevin Conroy

18,716,500

Jeffrey Elliott

5,123,530

D. Scott Coward

5,066,320

Graham Lidgard

2,084,980

Ana Hooker

3,945,020

Scott Johnson

--
As Of  31 Dec 2019